Monash IVF Group LtdASX: MVF

MVF FY26 Appendix 4E and Financial Report

· Issued by Monash IVF Group Ltd

Filed with ASX · · 98 pages · English

Underlying net profit after tax (NPAT) amounted to $16.1m which is below the guidance provided in June 2026 of between $17m to $18m. The result includes impact of the write-off of $1.4m (after tax) of prepaid assets. (1) The Directors consider EBITDA to be one of the key financial measures of the underlying performance of Monash IVF Group Limited. EBITDA is earnings before interest, tax, depreciat

Monash IVF Group Ltd on 6ix

Earlier from Monash IVF

Later from Monash IVF

All Monash IVF news releases